Management of Recurrent Clostridium difficile Infection During Intensive Chemotherapy and Stem Cell Transplantation for Leukemia: Case with Literature Review

Immunocompromised patients undergoing chemotherapy for hematologic malignancy and hematopoietic stem cell transplant (HSCT) recipients are at increased risk of Clostridium difficile (C. difficile) infection (CDI). The recurrence of infection and its associated morbidity and mortality are due to mult...

Descripción completa

Detalles Bibliográficos
Autores principales: Zahid, Umar, Sagar, FNU, Al Mohajer, Mayar, Majeed, Aneela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2018
Materias:
Infectious Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5984265/
https://www.ncbi.nlm.nih.gov/pubmed/29872594
http://dx.doi.org/10.7759/cureus.2413

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5984265/
https://www.ncbi.nlm.nih.gov/pubmed/29872594
http://dx.doi.org/10.7759/cureus.2413

Ejemplares similares